HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
India
Latest in
India
Biological E’s Covid-19 vaccine Corbevax gets DCGI approval as booster dose
Corbevax will be given after six months of the first two doses of either Covaxin or Covishield vaccines.
DCGI grants emergency use approval for Bharat Biotech’s Covaxin in children
In December last year, the DCGI approved the vaccine for emergency use in children of the age 12 to 18…
WHO halts supply of Bharat Biotech’s Covid-19 vaccine
Bharat Biotech is temporarily pausing vaccine production across its manufacturing sites to carry out upgrades.
DCGI grants EUA to Novavax’s Covid-19 vaccine for adolescents
In December last year, Covovax obtained EUA from DCGI for use in adults aged 18 years and older.
SII receives EUA grant recommendation from SEC for Covid-19 vaccine
The DCGI approved the vaccine for restricted use in an emergency situation for adults in December last year.
DCGI grants EUA to Biological E.’s Covid-19 vaccine for use in adolescents
The drug regulator granted approval to CORBEVAX in December last year for restricted use for emergency situations in adults.
CEPI, THSTI and Panacea to develop vaccines for betacoronaviruses
Funds of up to $12.5m will be offered to develop multi-epitope, nanoparticle-based vaccine candidates.